Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to understand cancer in unprecedented and patient-specific detail. By moving beyond traditional gene sequencing to measuring gene function, Function Oncology aims to identify optimal therapeutic opportunities for patients and advance the next generation of targeted cancer therapies.
Location: United States, California, San Diego
Employees: 1-10
Total raised: $28M
Founded date: 2023
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.04.2023 | Series A | $28M | - |
Mentions in press and media 4
| Date | Title | Description |
| 13.04.2023 | USA-based Function Oncology raises USD 28 million in Series A | California, USA-based precision medicine company advancing a CRISPR-powered personalized functional genomics platform to transform the future of targeted cancer treatment, Function Oncology, raised USD 28 million in Series A. The round took... |
| 12.04.2023 | Function Oncology launches from stealth and completes a $28M Series A round to target cancer treatment with a new CRISPR-enabled platform | - |
| 12.04.2023 | Function Oncology Raises $28M in Series A Financing | Function Oncology, a San Diego, CA-based precision medicine company, raised $28M in Series A funding. The round was led by a16z and Section 32, with participation from Casdin Capital and Alexandria Venture Investments. Led by Srinath Sampat... |
| - | Function Oncology | “Function Oncology” |